Ocular Therapeutix, Inc.
OCUL
$9.16
-$0.12-1.29%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -37.06% | 6.86% | -2.37% | -5.87% | -32.37% |
| Total Depreciation and Amortization | 2.89% | 16.65% | 4.19% | 4.59% | 3.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 80.96% | -18.98% | 26.35% | -14.55% | 80.00% |
| Change in Net Operating Assets | 145.79% | -156.36% | 575.36% | -90.02% | 544.64% |
| Cash from Operations | -21.65% | -6.95% | 8.17% | -23.66% | -13.29% |
| Capital Expenditure | -64.21% | 52.63% | -381.37% | 35.59% | -856.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -64.21% | 52.63% | -437.49% | 42.32% | -856.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.93% | 4,239.28% | -89.41% | 2,238.18% | -7.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.93% | 4,239.28% | -89.41% | 2,238.18% | -7.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -117.94% | 946.14% | -211.84% | 197.72% | -20.80% |